Skip to main content
Top
Published in: Diabetologia 10/2009

Open Access 01-10-2009 | Article

Associations between vascular co-morbidities and depression in insulin-naive diabetes patients: the DIAZOB Primary Care Diabetes study

Authors: B. Koopmans, F. Pouwer, R. A. de Bie, G. L. Leusink, J. K. L. Denollet, V. J. M. Pop

Published in: Diabetologia | Issue 10/2009

Login to get access

Abstract

Aims/hypothesis

The aim of the study was to determine the prevalence of depression in insulin-naive diabetes patients and to investigate the associations between different forms of vascular co-morbidity and depression.

Methods

Cross-sectional data were used from a primary-care sample of 1,269 insulin-naive (i.e. not using insulin therapy) diabetes patients participating in the DIAZOB Primary Care Diabetes study. Demographics, vascular co-morbidities, clinical and lifestyle characteristics, and psychosocial factors were assessed. Depression symptoms were measured with the Edinburgh Depression Scale, with a score >11 defined as depression. The χ 2 and Student’s t tests were used to compare groups with and without vascular co-morbidities. Rates and odds ratios of depression were calculated for each vascular co-morbidity, with diabetes only as the reference group, correcting for age and sex. Single and multiple logistic regression analyses were performed to test a more comprehensive model regarding the likelihood of depression in diabetes.

Results

The prevalence of depression was 11% in the total sample with little difference between the groups with and without any vascular co-morbidity (11.2% vs 10.0%). Single vascular co-morbidities were not associated with increased rates of depression. The final model predicting depression included: having multiple vascular co-morbidities compared with none; having less social support; having experienced a recent stressful life event; female sex; and being a smoker.

Conclusions/interpretation

Rates of depression in those with one additional vascular co-morbidity did not differ from patients with diabetes only. Vascular co-morbidities were only associated with higher depression scores in case of multiple co-morbidities.
Literature
1.
go back to reference Michaud CM, Murray CJ, Bloom BR (2001) Burden of disease—implications for future research. JAMA 285:535–539PubMedCrossRef Michaud CM, Murray CJ, Bloom BR (2001) Burden of disease—implications for future research. JAMA 285:535–539PubMedCrossRef
2.
go back to reference Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23:1165–1173PubMedCrossRef Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23:1165–1173PubMedCrossRef
3.
go back to reference Schram M, Baan C, Pouwer F (2009) Depression and quality of life in individuals with diabetes: a systematic review from the European Depression in Diabetes (EDID) Research Consortium. Curr Diabetes Rev 5:112–119PubMedCrossRef Schram M, Baan C, Pouwer F (2009) Depression and quality of life in individuals with diabetes: a systematic review from the European Depression in Diabetes (EDID) Research Consortium. Curr Diabetes Rev 5:112–119PubMedCrossRef
4.
go back to reference Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942PubMedCrossRef Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942PubMedCrossRef
5.
go back to reference Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160:3278–3285PubMedCrossRef Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160:3278–3285PubMedCrossRef
6.
go back to reference Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26:2822–2828PubMedCrossRef Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26:2822–2828PubMedCrossRef
7.
go back to reference Bruce DG, Davis WA, Starkstein SE, Davis TM (2005) A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48:2532–2539PubMedCrossRef Bruce DG, Davis WA, Starkstein SE, Davis TM (2005) A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48:2532–2539PubMedCrossRef
8.
go back to reference Pouwer F, Beekman AT, Nijpels G et al (2003) Rates and risks for co-morbid depression in patients with type 2 diabetes mellitus: results from a community-based study. Diabetologia 46:892–898PubMedCrossRef Pouwer F, Beekman AT, Nijpels G et al (2003) Rates and risks for co-morbid depression in patients with type 2 diabetes mellitus: results from a community-based study. Diabetologia 46:892–898PubMedCrossRef
9.
go back to reference de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630PubMed de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630PubMed
10.
go back to reference de Jonge P, Roy JF, Saz P, Marcos G, Lobo A (2006) Prevalent and incident depression in community-dwelling elderly persons with diabetes mellitus: results from the ZARADEMP project. Diabetologia 49:2627–2633PubMedCrossRef de Jonge P, Roy JF, Saz P, Marcos G, Lobo A (2006) Prevalent and incident depression in community-dwelling elderly persons with diabetes mellitus: results from the ZARADEMP project. Diabetologia 49:2627–2633PubMedCrossRef
11.
go back to reference Egede LE (2005) Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosom Med 67:46–51PubMedCrossRef Egede LE (2005) Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosom Med 67:46–51PubMedCrossRef
12.
go back to reference Engum A, Mykletun A, Midthjell K, Holen A, Dahl AA (2005) Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care 28:1904–1909PubMedCrossRef Engum A, Mykletun A, Midthjell K, Holen A, Dahl AA (2005) Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care 28:1904–1909PubMedCrossRef
13.
go back to reference Katon W, von Korff M, Ciechanowski P et al (2004) Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27:914–920PubMedCrossRef Katon W, von Korff M, Ciechanowski P et al (2004) Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27:914–920PubMedCrossRef
14.
go back to reference Knol MJ, Heerdink ER, Egberts AC et al (2007) Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med 69:300–305PubMedCrossRef Knol MJ, Heerdink ER, Egberts AC et al (2007) Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med 69:300–305PubMedCrossRef
15.
go back to reference Pawaskar MD, Anderson RT, Balkrishnan R (2007) Self-reported predictors of depressive symptomatology in an elderly population with type 2 diabetes mellitus: a prospective cohort study. Health Qual Life Outcomes 5:50PubMedCrossRef Pawaskar MD, Anderson RT, Balkrishnan R (2007) Self-reported predictors of depressive symptomatology in an elderly population with type 2 diabetes mellitus: a prospective cohort study. Health Qual Life Outcomes 5:50PubMedCrossRef
16.
go back to reference Nichols GA, Brown JB (2003) Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care 26:744–749PubMedCrossRef Nichols GA, Brown JB (2003) Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care 26:744–749PubMedCrossRef
17.
go back to reference Li C, Ford ES, Strine TW, Mokdad AH (2008) Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 31:105–107PubMedCrossRef Li C, Ford ES, Strine TW, Mokdad AH (2008) Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 31:105–107PubMedCrossRef
18.
go back to reference Schers H, Bor H, van den Hoogen H, van Weel C (2008) What went and what came? Morbidity trends in general practice from The Netherlands. Eur J Gen Pract 14(Suppl 1):13–24PubMedCrossRef Schers H, Bor H, van den Hoogen H, van Weel C (2008) What went and what came? Morbidity trends in general practice from The Netherlands. Eur J Gen Pract 14(Suppl 1):13–24PubMedCrossRef
19.
go back to reference Poortvliet MC, Schrijvers CTM, Baan CA (2007) Diabetes in Nederland. Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven Poortvliet MC, Schrijvers CTM, Baan CA (2007) Diabetes in Nederland. Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven
20.
go back to reference Koopmans B, Pouwer F, de Bie RA, van Rooij ES, Leusink GL, Pop VJ (2009) Depressive symptoms are associated with physical inactivity in patients with type 2 diabetes. The DIAZOB Primary Care Diabetes Study. Fam Pract 26:171–173PubMedCrossRef Koopmans B, Pouwer F, de Bie RA, van Rooij ES, Leusink GL, Pop VJ (2009) Depressive symptoms are associated with physical inactivity in patients with type 2 diabetes. The DIAZOB Primary Care Diabetes Study. Fam Pract 26:171–173PubMedCrossRef
21.
go back to reference WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus. WHO Department of Noncommunicable Disease Surveillance, Geneva, pp 1–59 WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus. WHO Department of Noncommunicable Disease Surveillance, Geneva, pp 1–59
22.
go back to reference Turner R, Stratton I, Horton V et al (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288–1293PubMedCrossRef Turner R, Stratton I, Horton V et al (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288–1293PubMedCrossRef
23.
go back to reference Fourlanos S, Dotta F, Greenbaum CJ et al (2005) Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206–2212PubMedCrossRef Fourlanos S, Dotta F, Greenbaum CJ et al (2005) Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206–2212PubMedCrossRef
24.
go back to reference Becker F (1985) Exploration of arterial function with noninvasive technics. Results in chronic arterial occlusive disease of the lower limbs according to Leriche and Fontaine classification. Int Angiol 4:311–322PubMed Becker F (1985) Exploration of arterial function with noninvasive technics. Results in chronic arterial occlusive disease of the lower limbs according to Leriche and Fontaine classification. Int Angiol 4:311–322PubMed
25.
go back to reference Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC (2000) International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 16(Suppl 1):S84–S92PubMedCrossRef Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC (2000) International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 16(Suppl 1):S84–S92PubMedCrossRef
26.
go back to reference Werkgroep Diabetische voet (2006) Richtlijn Diabetische Voet. CBO Werkgroep Diabetische voet (2006) Richtlijn Diabetische Voet. CBO
27.
go back to reference Richtlijn Diabetische nefropathie (2006) Monitoring, diagnostiek en behandeling. Nederlandsche Internisten Vereeniging, Utrecht Richtlijn Diabetische nefropathie (2006) Monitoring, diagnostiek en behandeling. Nederlandsche Internisten Vereeniging, Utrecht
28.
go back to reference Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMed Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMed
29.
go back to reference Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef
30.
go back to reference Diabetische Retinopathie Richtlijnen (2006) Screening, diagnostiek en behandeling. Nederlands Oogheelkundig Gezelschap, Nijmegen Diabetische Retinopathie Richtlijnen (2006) Screening, diagnostiek en behandeling. Nederlands Oogheelkundig Gezelschap, Nijmegen
31.
go back to reference IDF Clinical Guidelines Task Force (2005) Global guideline for type 2 diabetes. International Diabetes Federation, Brussels IDF Clinical Guidelines Task Force (2005) Global guideline for type 2 diabetes. International Diabetes Federation, Brussels
32.
go back to reference Beekman AT, Deeg DJ, van Tilburg T, Smit JH, Hooijer C, van Tilburg W (1995) Major and minor depression in later life: a study of prevalence and risk factors. J Affect Disord 36:65–75PubMedCrossRef Beekman AT, Deeg DJ, van Tilburg T, Smit JH, Hooijer C, van Tilburg W (1995) Major and minor depression in later life: a study of prevalence and risk factors. J Affect Disord 36:65–75PubMedCrossRef
33.
go back to reference Cox JL, Chapman G, Murray D, Jones P (1996) Validation of the Edinburgh Postnatal Depression Scale (EPDS) in non-postnatal women. J Affect Disord 39:185–189PubMedCrossRef Cox JL, Chapman G, Murray D, Jones P (1996) Validation of the Edinburgh Postnatal Depression Scale (EPDS) in non-postnatal women. J Affect Disord 39:185–189PubMedCrossRef
34.
go back to reference Cox JL, Holden JM, Sagovsky R (1987) Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150:782–786PubMedCrossRef Cox JL, Holden JM, Sagovsky R (1987) Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150:782–786PubMedCrossRef
35.
go back to reference Pop VJ, Komproe IH, van Son MJ (1992) Characteristics of the Edinburgh Post Natal Depression Scale in The Netherlands. J Affect Disord 26:105–110PubMedCrossRef Pop VJ, Komproe IH, van Son MJ (1992) Characteristics of the Edinburgh Post Natal Depression Scale in The Netherlands. J Affect Disord 26:105–110PubMedCrossRef
36.
go back to reference Matthey S, Barnett B, Kavanagh DJ, Howie P (2001) Validation of the Edinburgh Postnatal Depression Scale for men, and comparison of item endorsement with their partners. J Affect Disord 64:175–184PubMedCrossRef Matthey S, Barnett B, Kavanagh DJ, Howie P (2001) Validation of the Edinburgh Postnatal Depression Scale for men, and comparison of item endorsement with their partners. J Affect Disord 64:175–184PubMedCrossRef
37.
go back to reference Becht MC, Van Erp CF, Teeuwisse TM, Van Heck GL, Van Son MJ, Pop VJ (2001) Measuring depression in women around menopausal age: towards a validation of the Edinburgh Depression Scale. J Affect Disord 63:209–213PubMedCrossRef Becht MC, Van Erp CF, Teeuwisse TM, Van Heck GL, Van Son MJ, Pop VJ (2001) Measuring depression in women around menopausal age: towards a validation of the Edinburgh Depression Scale. J Affect Disord 63:209–213PubMedCrossRef
38.
go back to reference Murray L, Carothers AD (1990) The validation of the Edinburgh Post-natal Depression Scale on a community sample. Br J Psychiatry 157:288–290PubMedCrossRef Murray L, Carothers AD (1990) The validation of the Edinburgh Post-natal Depression Scale on a community sample. Br J Psychiatry 157:288–290PubMedCrossRef
39.
go back to reference Nyklicek I, Scherders MJ, Pop VJ (2004) Multiple assessments of depressive symptoms as an index of depression in population-based samples. Psychiatry Res 128:111–116PubMedCrossRef Nyklicek I, Scherders MJ, Pop VJ (2004) Multiple assessments of depressive symptoms as an index of depression in population-based samples. Psychiatry Res 128:111–116PubMedCrossRef
40.
go back to reference O’Hara MW, Rehm LP, Campbell SB (1983) Postpartum depression. A role for social network and life stress variables. J Nerv Ment Dis 171:336–341PubMedCrossRef O’Hara MW, Rehm LP, Campbell SB (1983) Postpartum depression. A role for social network and life stress variables. J Nerv Ment Dis 171:336–341PubMedCrossRef
41.
go back to reference Rubin RR (1997) Psychotherapy in diabetes mellitus. Semin Clin Neuropsychiatry 2:72–81PubMed Rubin RR (1997) Psychotherapy in diabetes mellitus. Semin Clin Neuropsychiatry 2:72–81PubMed
42.
go back to reference Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823PubMedCrossRef Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823PubMedCrossRef
44.
go back to reference Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56PubMedCrossRef Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56PubMedCrossRef
45.
go back to reference Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19:113–122PubMed Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19:113–122PubMed
46.
go back to reference Herpertz S, Albus C, Lichtblau K, Kohle K, Mann K, Senf W (2000) Relationship of weight and eating disorders in type 2 diabetic patients: a multicenter study. Int J Eat Disord 28:68–77PubMedCrossRef Herpertz S, Albus C, Lichtblau K, Kohle K, Mann K, Senf W (2000) Relationship of weight and eating disorders in type 2 diabetic patients: a multicenter study. Int J Eat Disord 28:68–77PubMedCrossRef
47.
go back to reference Friedman MA, Brownell KD (1995) Psychological correlates of obesity: moving to the next research generation. Psychol Bull 117:3–20PubMedCrossRef Friedman MA, Brownell KD (1995) Psychological correlates of obesity: moving to the next research generation. Psychol Bull 117:3–20PubMedCrossRef
48.
go back to reference Kawada T, Suzuki S (2001) Obesity has an inverse relationship with a depressive state. J Occup Health 43:371–374CrossRef Kawada T, Suzuki S (2001) Obesity has an inverse relationship with a depressive state. J Occup Health 43:371–374CrossRef
49.
go back to reference Ruige J, Batstra M, Aanstoot H et al (1997) Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population. The Hoorn Study. Diabetes Care 20:1108–1110PubMedCrossRef Ruige J, Batstra M, Aanstoot H et al (1997) Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population. The Hoorn Study. Diabetes Care 20:1108–1110PubMedCrossRef
Metadata
Title
Associations between vascular co-morbidities and depression in insulin-naive diabetes patients: the DIAZOB Primary Care Diabetes study
Authors
B. Koopmans
F. Pouwer
R. A. de Bie
G. L. Leusink
J. K. L. Denollet
V. J. M. Pop
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1460-2

Other articles of this Issue 10/2009

Diabetologia 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.